Biotech Values

[JJM760]

I know how much you all love Arena, but here goes. Does anyone see any value/potential in Lorq in obese diabetics? The Bloom data is due in few weeks and I'm wondering what impact positive data will have on the stock price. I remember Dew felt that Eisai was going to drop Lorq after reviewing the crl, thinking Lorq on it's own was not worth the investment and the market for diabetes was not significant enough. I am still holding a few from a bad trade after the panel rejection and considering my options. Thanks in advance.